LSV Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387M Sell
818,427
-7,440
-0.9% -$3.75M 0.83% 24
2025
Q4
$386M Sell
825,867
-17,756
-2% -$8.24M 0.84% 24
2025
Q3
$360M Sell
843,623
-25,226
-3% -$9.78M 0.79% 23
2025
Q2
$333M Buy
868,849
+3,396
+0.4% +$1.22M 0.78% 28
2025
Q1
$299M Sell
865,453
-1,344
-0.2% -$432K 0.72% 30
2024
Q4
$260M Sell
866,797
-36,568
-4% -$12.8M 0.6% 45
2024
Q3
$367M Sell
903,365
-28,209
-3% -$10.3M 0.79% 27
2024
Q2
$299M Sell
931,574
-41,650
-4% -$13.5M 0.66% 37
2024
Q1
$325M Sell
973,224
-81,549
-8% -$24.9M 0.67% 39
2023
Q4
$286M Sell
1,054,773
-68,480
-6% -$16.9M 0.62% 41
2023
Q3
$276M Sell
1,123,253
-17,740
-2% -$4.85M 0.64% 37
2023
Q2
$346M Sell
1,140,993
-48,000
-4% -$13.3M 0.76% 27
2023
Q1
$314M Sell
1,188,993
-20,500
-2% -$5.21M 0.7% 30
2022
Q4
$290M Sell
1,209,493
-103,510
-8% -$23.2M 0.64% 32
2022
Q3
$241M Buy
1,313,003
+16,871
+1% +$3.36M 0.57% 48
2022
Q2
$218M Sell
1,296,132
-20,098
-2% -$4.32M 0.47% 63
2022
Q1
$330M Sell
1,316,230
-51,132
-4% -$12.8M 0.61% 39
2021
Q4
$351M Sell
1,367,362
-132,380
-9% -$32.4M 0.62% 42
2021
Q3
$364M Sell
1,499,742
-936,780
-38% -$229M 0.66% 35
2021
Q2
$504M Sell
2,436,522
-188,785
-7% -$38.5M 0.86% 20
2021
Q1
$494M Sell
2,625,307
-229,714
-8% -$40.5M 0.84% 22
2020
Q4
$470M Sell
2,855,021
-542,300
-16% -$79.3M 0.85% 22
2020
Q3
$424M Sell
3,397,321
-205,895
-6% -$25.5M 0.87% 21
2020
Q2
$350M Sell
3,603,216
-345,970
-9% -$36M 0.73% 30
2020
Q1
$355M Sell
3,949,186
-195,161
-5% -$25.3M 0.86% 24
2019
Q4
$613M Sell
4,144,347
-181,631
-4% -$24.4M 0.95% 17
2019
Q3
$521M Sell
4,325,978
-252,124
-6% -$32.6M 0.86% 21
2019
Q2
$619M Sell
4,578,102
-147,270
-3% -$18.6M 1% 17
2019
Q1
$616M Sell
4,725,372
-164,293
-3% -$22.1M 0.99% 17
2018
Q4
$609M Sell
4,889,665
-584,727
-11% -$78.5M 1.08% 13
2018
Q3
$762M Buy
5,474,392
+15,004
+0.3% +$1.87M 1.14% 13
2018
Q2
$560M Buy
5,459,388
+457,752
+9% +$46.3M 0.88% 19
2018
Q1
$485M Buy
5,001,636
+43,700
+0.9% +$4.24M 0.77% 26
2017
Q4
$436M Sell
4,957,936
-80,010
-2% -$6.43M 0.69% 35
2017
Q3
$401M Buy
5,037,946
+1,130,007
+29% +$90.9M 0.66% 36
2017
Q2
$341M Buy
3,907,939
+203,290
+5% +$17.2M 0.61% 43
2017
Q1
$330M Buy
3,704,649
+230,796
+7% +$19.2M 0.6% 44
2016
Q4
$257M Sell
3,473,853
-99,687
-3% -$7.47M 0.47% 61
2016
Q3
$270M Buy
3,573,540
+37,110
+1% +$2.84M 0.53% 51
2016
Q2
$272M Buy
3,536,430
+279,198
+9% +$22M 0.56% 48
2016
Q1
$254M Buy
3,257,232
+170,200
+6% +$11.9M 0.53% 53
2015
Q4
$209M Buy
3,087,032
+2,879,410
+1,387% +$201M 0.45% 72
2015
Q3
$16.1M Buy
207,622
+28,900
+16% +$2.56M 0.04% 304
2015
Q2
$16.2M Buy
178,722
+95,122
+114% +$7.62M 0.03% 303
2015
Q1
$6.29M Buy
83,600
+52,100
+165% +$3.74M 0.01% 443
2014
Q4
$2.31M Buy
+31,500
New +$2.21M ﹤0.01% 590

Other funds holding HCA

LSV Asset Management's HCA Position: Q1 2026 in Review

LSV Asset Management reduced its HCA Healthcare (HCA) stake by 0.9% in Q1 2026, selling an estimated $3.75M and leaving 818,427 shares worth $387M. The position accounts for 0.83% of the portfolio, ranked #24.

LSV Asset Management first reported a position in HCA in Q4 2014 and has held it in 46 quarters since. The position peaked at $762M in Q3 2018. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • LSV Asset Management held 818,427 shares of HCA Healthcare worth $387M as of Q1 2026.
  • LSV Asset Management sold 7,440 HCA Healthcare shares in Q1 2026, an estimated $3.75M.
  • HCA Healthcare made up 0.83% of LSV Asset Management's portfolio in Q1 2026, its #24 holding.
  • LSV Asset Management first reported a position in HCA Healthcare in Q4 2014 and has held it in 46 quarters since.
  • LSV Asset Management's HCA Healthcare position peaked at $762M in Q3 2018.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.